Skip to main content
George Van Buren II, MD, General Surgery, Houston, TX, Texas Children's Hospital

GeorgeVan BurenIIMD

General Surgery • Houston, TX

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)

Physician

Join to view full profile

Dr. Van Buren is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Van Buren's full profile

Already have an account?

Summary

  • George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.
    Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer, colorectal cancer, and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.
    During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology. Specifically, his training had a heavy emphasis on upper gastrointestinal and hepatobiliary malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery and minimally invasive lower gastrointestinal surgery.
    Dr. Van Buren is active in both patient care and research. He has been involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials.

Education & Training

  • Rice University
    Rice UniversityNo Degree, Certificate in Healthcare Management, 2014 - 2015
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2012
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Surgery, 2003 - 2010
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2007
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2003
  • The University of Texas System
    The University of Texas SystemB.A., Biology, 1996 - 1999
  • Johns Hopkins University
    Johns Hopkins UniversityBachelor's, Biology, 1995 - 1996

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2007 - 2025
  • PA State Medical License
    PA State Medical License 2010 - 2012
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors Houstonia Magazine, 2015
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Pancreas Club Resident/ Fellow Award 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Pancreaticoduodenectomy Without Drains: Interpretation of the Evidence  
    Van Buren G 2nd, Fisher WE, Ann Surg, 1/1/2015
  • Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy  
    Mohammed S, Evans C, Hodges SE, Silberfein E, Artinyan A, Mo Q, Issazadeh M, McElhany AL, Fisher WE, HPB (Oxford), 1/29/2013
  • An assessment of the necessity of transfusion during pancreatoduodenectomy  
    Ross A, Mohammed S, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, Surgery, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Operative Techniques in Surgery 
    Chapter: Chapter 33: Pancreaticoduodenectomy: Resection 
    Van Buren G 2nd, Fisher WELippincott, Williams, and Wilkins, Philadelphia, PAEdition 1st,2014
  • Antiangiogenic Agents in Cancer Therapy 
    Chapter: Chapter 18: Challenges in translating anti-angiogenic therapy from the bench to bedside 
    Ellis LM, Dallas NA, Lim S, Xia L, Fan F, Gray MJHumana Press, Totowa, NJEdition 2nd,2007

Abstracts/Posters

  • The Impact of Level One Data on Pancreatic Surgical Practice
    Mederos MA, McElhany A, Mohammed S, Fisher WE, Debakey Department of Surgery Research Day, Houston, TX, 1/3/2015
  • The Impact Of Inappropriate Blood Transfusion During Pancreaticoduodenectomy
    Mohammed S, Ross A, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, ASC 2013, New Orleans, 1/1/2013
  • Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarc...
    Ramanathan R, Krasinskas A, Smith R, Abood G, Shaui Y, Potter D, Bahary N, Lembersky B, Zureikat AH, Bartlett DL, Zeh HJ, Moser AJ, ASCO 2012 Gastrointestinal Cancers Symposium, 1/1/2012
  • Join now to see all

Lectures

  • Faculty Education and Development: Maintenance of Certification 
    Baylor College of Medicine - 1/9/2015
  • A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage 
    1/1/2014
  • Colon Adenocarcinoma Lymph Node Analysis 
    1/1/2014
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

External Links

Dr. George Van Buren, Dr. George Van Buren, MD, Dr. G Van Buren